GRK 1172: „BIOLOGICALS“ Research, Development and Safety of Biopharmaceuticals

Prof. Dr. Josef Pfeilschifter Institut für Allgemeine Pharmakologie und Toxikologie,

pharmazentrum frankfurt / ZAFES, Goethe-Universität Frankfurt

Selection of the topic „Biologicals“: Drug Research, Development and Safety

FIRST

Structured PhD training

PhD students of the GRK1172: Where do they come from and where do they go to?

„Translational biomedical research“:

• Graduates from natural sciences, medicine,

pharmacy and biotechnology

• Qualifying year for BA students

(FH students)

• Stipends for

medical students

Until 2009: 45 PhD students in GRK1172)

Qualifying for „drug research and development“:

• Research institutions (universities, Fraunhofer, Leibniz and others)

• Pharmaceutical companies and biotech companies

• Reasearch organisations und regulatory authorities

Dr. phil. nat., Dr. rer. med., Dr. med., MD/PhD

Qualifying concept: GRK 1172 Core Curriculum!

Lipid Signalling (Co-ordinators: G. Geißlinger, J. Pfeilschifter, D. Steinhilber)

FOG 784, Hans Kröner-Graduiertenkolleg

Redox Signalling (Co-ordinators: B. Brüne, R. Brandes)

SFB 815 & integrated GK

GK1172 „Biologicals“ (Co-ordinators: J. Pfeilschifter, H. Radeke)

TRIP – small molecules in drug research (Co-ordinators: G. Geisslinger, B. Brüne)

Oncogenic Signalling

(Co-ordinators:

H. Serve, R. Marschalek,

S. Fulda)

LOEWE OSF

Cardiovascular

Signalling

(Co-ordinators:

S. Dimmeler, I. Fleming,

K. Plate)

ECCPS,

TR-SFB 23 & integrated GK

SFB 834

Goethe Graduate Academy

Graduate Centre Biomed

FIRST

Recruitment process of PhD students

SELECTED FIRST PhD STUDENTS

GRK 1172: „BIOLOGICALS“ Research, Development and Safety of Biopharmaceuticals

Prof. Dr. Josef Pfeilschifter Institut für Allgemeine Pharmakologie und Toxikologie,

pharmazentrum frankfurt / ZAFES, Goethe-Universität Frankfurt

Structure of the GRK 1172: Projects comprising different classes of drugs and phases of development

Courses for a PhD student with a master in

natural sciences

FIRST – „elective courses“

From Target to Drug – TNFa as example

Crash Course in Molecular and Clinical Immunology

Molecular Virology

Tumour Biology

Biopharmaceuticals

Regenerative Medicine – from bench to bedside

Cardiovascular Biology

Current Highlights in Molecular Medicine

Current Highlights in Chemical Biology & Medicinal Chemistry